Thought Leader Liaison (TLL), West
Tonix Pharmaceuticals
This listing was originally posted on Tonix Pharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Drug products linked to this role
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moTonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X.
*Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication.
Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.
Position Overview
The Associate Director Thought Leader Liaison (TLL), Fibromyalgia, will directly report into the Director, Commercial Strategy and will lead executional efforts in regional and local engagement with existing and emerging Key Opinion Leaders (KOLs), Advocacy Groups and Professional Societies to develop and implement education that helps simplify the early Fibromyalgia patient journey from diagnosis through treatment and monitoring. This will include identifying new and emerging opinion leaders and appropriately engaging KOLs to support speaker bureau activities, and assessing speaker programs for meaningfulness, effectiveness, education, and compliance with company policies.
The TLL role is a field-based role (non-sales focused) position, working closely with U.S. Key Fibromyalgia Thought Leaders (KOLs) to ensure cross-functional commercial resources are made available as appropriate. The three primary (but not exclusive) areas of focus for TLL are KOL engagement, executive encounter management, and supporting the Fibromyalgia community.
Essential Duties
Necessary Skills and Abilities
Educational Requirements
Experience Requirements
*Please note that Tonix does not offer sponsorship for this role.
Recruitment & Staffing Agencies
Tonix does not accept agency resumes unless contacted directly by internal Tonix Talent Acquisition. Please do not forward resumes to Tonix employees or any other company location; Tonix is not responsible for any fees related to unsolicited resumes.
Compensation & Benefits
Tonix provides a comprehensive compensation and benefits package which includes:
Tonix provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, genetics, or any other characteristic protected by law. In addition to federal law requirements, Tonix complies with applicable state and local laws governing nondiscrimination in employment. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfers, leaves of absence, compensation, and training. Tonix expressly prohibits any form of workplace harassment based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic, information, disability, veteran status, or any other characteristic protected by law.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Tonix Pharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
CNS Disorders
Upgrade to Pro to access all 23 linked drug products and competitive data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo